Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund is a venture capital that invests in therapeutic approaches and technologies

Boehringer Ingelheim Venture Fund is a venture capital that invests in therapeutic approaches and technologies. The firm was founded in 2010, in Ingelheim Am Rhein, Rheinlan-Pfalz, Germany, and is a sub-organization of Boehringer Ingelheim.

The firm invests in biotechnology companies that drive innovation in biomedical research. Searching for significant enhancements in patient care through pioneering science and its clinical translation by creating long-term relationships with entrepreneurs and scientists.

Timeline

Invested in

Patents

Funding Rounds Participated In

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

opnMe.com: the Boehringer Ingelheim ́s Open Innovation Portal -Dr Florian MONTEL Boehringer Ingelheim

November 16, 2021

Virtual Tour Boehringer Ingelheim

April 12, 2021

News

Title
Author
Date
Publisher
Description
Matteo Tisei
July 17, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Nick Paul
July 6, 2020
FierceBiotech
Boehringer Ingelheim has opened a site in Shanghai to connect its R&D, business development and venture capital groups to Chinese drug developers. The site brings together all the units involved in the identification and support of promising drug development projects.

References

Golden logo
By using this site, you agree to our Terms & Conditions.